MSC teams with Quadrise on MSAR fuel trials

In the UK, Quadrise has signed a Joint Development Agreement with MSC Shipmanagement Limited of Cyprus (“MSC”), a 100% subsidiary of MSC Mediterranean Shipping Company SA headquartered in Geneva, to carry out an MSAR® Operational Trial on commercial container vessels in the MSC global fleet commencing in 2021 with, subject to further agreement, subsequent commercial rollout upon success.  

Initial activities under the JDA will include project initiation, definition, high-level scoping and feasibility activities of the overall trial. The initial activities are to be completed within three months.

Contingent on the outcome of the Initial Activities the parties will progress and define the project roadmap during Q2 2021 in preparation for the execution of one or more trials commencing in H2 2021 on representative commercial vessels in MSC’s global fleet. Upon completion and success of Phase 1, and subject to further agreement between the parties, the JDA envisages subsequent commercial roll-out across the MSC global fleet.

Phase 1 will see the testing of MSAR® fuel in a large MAN ME and/or a Wärtsilä/WinGD Flex 2-stroke engine so as to obtain Letter Of No Objection (“LONO”) approvals from the respective engine manufacturers.  Phase 1 testing may also incorporate testing of QFI’s new bioMSARTM biofuel.